About Policy Lab
Policy Lab is an independent health resource built to help people navigate two big decisions: whether to consider a clinical trial as a treatment path, and how to evaluate the medications and treatment options already on the market. Clinical trials are our starting point and our primary focus. Treatment and medication insights are how we help our audience make sense of the rest of their options.
What we do
Clinical trials are the core of Policy Lab. We maintain a searchable database of over 500,000 clinical trials offered across the United States, sourced directly from ClinicalTrials.gov (the NIH’s official public registry). Our guides cover trials for weight management, chronic conditions like diabetes, hypertension, chronic kidney disease, and inflammatory disease, as well as cancer, autoimmune conditions, mental health, and many other categories. For any condition we cover, we work to answer the questions people are already asking as they consider whether a trial is right for them: How do I qualify? What are the risks? How is compensation handled? What happens after the trial ends?
Alongside the trial database, we publish treatment and medication insights on the options that are commercially available today. This includes the telehealth providers, pharmacies, and prescription programs that dispense weight-loss medication (GLP-1s including semaglutide and tirzepatide), hormone therapies (testosterone replacement therapy, hormone replacement therapy), and adjacent categories. For each of these, we review the providers our audience is already encountering when they search: how each one operates, what the actual costs are, and where the trade-offs are, so readers can weigh their treatment options against the trial options.
Both sides of the site serve the same audience: people who want a full picture of what’s available to them before making a healthcare decision.
How we’re structured
Policy Lab is operated by Pacific Shores Research Group, LLC, an independent US publisher founded in 2017. Policy Lab was Pacific Shores’ flagship brand at launch and remains one of its principal properties. We are not affiliated with any of the telehealth providers, pharmacies, or pharmaceutical manufacturers we cover, and we are not affiliated with ClinicalTrials.gov, the NIH, or any government agency.
Contact: info@pacshores.co for general inquiries and corrections.
Editorial leadership
Trina Daniels, Director of Editorial & Content Operations — Trina has spent decades building editorial systems for YMYL and regulated publishing environments, where getting it wrong is a compliance problem. She has led concurrent editorial teams across healthcare, addiction treatment, veterinary medicine, and other regulated verticals. At Policy Lab she oversees editorial standards, ranking methodology, contributor recruitment, and clinical-trial content curation, and works closely with our credentialed contributors to translate complex clinical knowledge into content that is clear, compliant, and useful.
Policy Lab does not designate a single medical reviewer for the site. Instead, clinical review is provided collectively by our named credentialed contributors, each of whom reviews content within their scope of practice. A registered nurse reviews nursing and care-flow content. A pharmacist reviews pharmacology and medication comparisons. A dietitian reviews nutrition content. A physician reviews clinical-medicine content. Where a claim falls outside any one contributor’s scope, we route it to the contributor whose credentials fit best, or we consult more than one before publishing.
Our contributors
Every ranked article and clinical review on Policy Lab is written or reviewed by a named contributor with credentials relevant to the topic. Each byline links to an author profile that lists credentials, licensure, expertise areas, and, where applicable, LinkedIn, ORCID, and PubMed identifiers so readers can independently verify a contributor’s background.
Our named contributors include:
- Stephanie Wright, RN — Registered nurse and medical writer. Covers testosterone replacement therapy, hormone replacement therapy, GLP-1 medications, and telehealth flow.
- Brenda Peralta, RD, CDE — Registered dietitian and certified diabetes educator. Covers weight loss, GLP-1 medications, nutrition, and diabetes management.
- Gerardo Sison, PharmD — Doctor of pharmacy and medical writer. Covers GLP-1 medications, semaglutide, compounded medications, and pharmacology.
- Dr. Jody-Ann McLean, MBBCH — Physician contributor. Covers clinical medicine, pathology, and medical research interpretation.
- Additional contributors are listed on each article’s byline and reachable through their individual author pages.
Clinical-trial guide pages compiled from ClinicalTrials.gov data carry a Policy Lab byline that discloses the underlying data source, the refresh cadence, and how the narrative summaries are generated. The trial data is pulled from the NIH’s public registry rather than authored by a single named contributor, and we want that visible so readers know exactly where the information came from.
Editorial independence and how we’re funded
Policy Lab is free for readers. We are supported by two revenue streams, both clearly disclosed on the pages where they apply.
Featured Trials. On the clinical-trial side of the site, we accept compensation from certain trial sponsors and recruitment partners to feature specific trials more prominently. Compensated placements are always labeled “Featured Trial” so readers can distinguish them from the broader ClinicalTrials.gov listings. The underlying trial database itself is not paid placement; it is a direct mirror of publicly registered trials that any reader can also search on ClinicalTrials.gov.
Affiliate relationships on the treatment side. On the treatment and medication side of the site, we earn commission through affiliate relationships with some (not all) of the providers we cover. Affiliate arrangements do not influence which providers appear in a ranking, where they appear, or what we say about them. Every affiliate arrangement is disclosed on the article where the CTA appears, and where we’ve negotiated a Policy Lab-exclusive rate on a reader’s behalf, that is disclosed alongside the price. Our full approach to reviewing providers, verifying claims, and handling conflicts of interest is documented in our Ranking Methodology.
Featured Trials and affiliate relationships fund the operation. Editorial independence is a foundational principle of the site.
Corrections and factual disputes
If you see something on Policy Lab that you believe is wrong, out of date, or misleading, tell us at info@pacshores.co with the article URL, the specific claim you believe is incorrect, and a source if you have one. We acknowledge every correction request within one week and, where a correction is warranted, publish the fix with a dated note on the article that says what was changed and why.
What we don’t do
We don’t publish sponsored content presented as editorial. We don’t accept payment to change ranking positions or to remove negative reviews. We don’t publish clinical trials as regular listings when they are actually paid placements; Featured Trials are always labeled as such. We are not a medical practice and we do not provide medical advice. Every article carries its own disclaimer, and we encourage readers to consult a licensed clinician before making decisions about treatment or trial participation.
Last updated: August 12, 2026